In Vitro Assessment of Magnetic Liposomal Paclitaxel Nanoparticles as a Potential Carrier for the Treatment of Ovarian Cancer

Sara Yousefi Aldashi ¹ , Zahra Saffari ², Hasan Ebrahimi Shahmabadi ³ * , Azim Akbarzadeh ² *

Cited by CrossRef: 2

1- Dong Y, Zhang C, Zhang Q, Li Z, Wang Y, Yan J, Wu G, Qiu L, Zhu Z, Wang B, Gu H, Zhang Y. Identification of nanoparticle-mediated siRNA-ASPN as a key gene target in the treatment of keloids. Front Bioeng Biotechnol. 2022;10 [Crossref]

2- Kashyap A, Kumari M, Singh A, Mukherjee K, Maity D. Current development of theragnostic nanoparticles for women’s cancer treatment. Biomed Mater. 2024;19(4):042001 [Crossref]